Healthcare provider profile · identity verified

Alba Schultz, NP

Nurse Practitioner · EUGENE, OR · NPI 1801164926

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	913	428
Levothyroxine Sodium	Levothyroxine Sodium	718	320
Lisinopril	Lisinopril	524	278
Losartan Potassium	Losartan Potassium	475	239
Amlodipine Besylate	Amlodipine Besylate	435	214
Gabapentin	Gabapentin	419	180
Omeprazole	Omeprazole	364	160
Metformin Hcl	Metformin Hcl	285	136
Metoprolol Succinate	Metoprolol Succinate	260	137
Trazodone Hcl	Trazodone Hcl	234	104
Furosemide	Furosemide	215	94
Sertraline Hcl	Sertraline Hcl	208	84
Hydrochlorothiazide	Hydrochlorothiazide	193	99
Metoprolol Tartrate	Metoprolol Tartrate	193	95
Metformin Hcl Er	Metformin Hcl	184	87
Pantoprazole Sodium	Pantoprazole Sodium	176	83
Eliquis	Apixaban	173	64
Albuterol Sulfate Hfa	Albuterol Sulfate	171	90
Rosuvastatin Calcium	Rosuvastatin Calcium	170	82
Simvastatin	Simvastatin	169	91
Tamsulosin Hcl	Tamsulosin Hcl	169	85
Duloxetine Hcl	Duloxetine Hcl	163	60
Potassium Chloride	Potassium Chloride	161	64
Ozempic	Semaglutide	131	54
Jardiance	Empagliflozin	122	51
Pravastatin Sodium	Pravastatin Sodium	118	59
Allopurinol	Allopurinol	112	51
Alendronate Sodium	Alendronate Sodium	109	48
Carvedilol	Carvedilol	106	49
Fluoxetine Hcl	Fluoxetine Hcl	106	47
Glipizide Er	Glipizide	105	47
Pregabalin	Pregabalin	104	39
Spironolactone	Spironolactone	97	50
Fluticasone Propionate	Fluticasone Propionate	93	45
Buspirone Hcl	Buspirone Hcl	89	33
Mirtazapine	Mirtazapine	86	24
Citalopram Hbr	Citalopram Hydrobromide	84	41
Tizanidine Hcl	Tizanidine Hcl	84	28
Escitalopram Oxalate	Escitalopram Oxalate	83	38
Ezetimibe	Ezetimibe	80	37
Famotidine	Famotidine	77	36
Venlafaxine Hcl Er	Venlafaxine Hcl	77	31
Trulicity	Dulaglutide	75	28
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	73	43
Ibuprofen	Ibuprofen	73	28
Montelukast Sodium	Montelukast Sodium	73	38
Glipizide	Glipizide	71	40
Clopidogrel	Clopidogrel Bisulfate	66	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	64	29
Pioglitazone Hcl	Pioglitazone Hcl	57	22
Donepezil Hcl	Donepezil Hcl	56	17
Ondansetron Odt	Ondansetron	55	34
Atenolol	Atenolol	54	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	28
Lovastatin	Lovastatin	54	28
Meloxicam	Meloxicam	52	32
Bupropion Xl	Bupropion Hcl	51	29
Finasteride	Finasteride	51	24
Isosorbide Mononitrate Er	Isosorbide Mononitrate	49	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	49	28
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	49	24
Nystatin	Nystatin	48	26
Quetiapine Fumarate	Quetiapine Fumarate	44	28
Hydroxyzine Hcl	Hydroxyzine Hcl	43	30
Oxybutynin Chloride Er	Oxybutynin Chloride	43	19
Sumatriptan Succinate	Sumatriptan Succinate	41	15
Chlorthalidone	Chlorthalidone	40	19
Bupropion Hcl Sr	Bupropion Hcl	38	18
Estradiol	Estradiol	38	26
Topiramate	Topiramate	38	14
Mounjaro	Tirzepatide	36	18
Propranolol Hcl Er	Propranolol Hcl	36	14
Aripiprazole	Aripiprazole	35	11
Acyclovir	Acyclovir	34	17
Celecoxib	Celecoxib	34	15
Ipratropium Bromide	Ipratropium Bromide	34	suppressed
Ketoconazole	Ketoconazole	33	18
Doxazosin Mesylate	Doxazosin Mesylate	32	11
Levetiracetam	Levetiracetam	32	suppressed
Paroxetine Hcl	Paroxetine Hcl	32	19
Prazosin Hcl	Prazosin Hcl	32	suppressed
Synthroid	Levothyroxine Sodium	32	14
Xarelto	Rivaroxaban	32	19
Advair Hfa	Fluticasone Propion/Salmeterol	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	23
Amitriptyline Hcl	Amitriptyline Hcl	30	15
Breo Ellipta	Fluticasone/Vilanterol	30	suppressed
Risperidone	Risperidone	30	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	29	14
Propranolol Hcl	Propranolol Hcl	29	19
Baclofen	Baclofen	28	17
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	28	14
Oxybutynin Chloride	Oxybutynin Chloride	28	12
Valacyclovir	Valacyclovir Hcl	28	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Naproxen	Naproxen	26	16
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	25
Diclofenac Sodium	Diclofenac Sodium	25	13
Ropinirole Hcl	Ropinirole Hcl	25	11
Lidocaine	Lidocaine	24	17
Methocarbamol	Methocarbamol	24	12
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	13
Myrbetriq	Mirabegron	22	suppressed
Olanzapine	Olanzapine	22	suppressed
Promethazine Hcl	Promethazine Hcl	22	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Lacosamide	Lacosamide	20	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	20	suppressed
Varenicline Tartrate	Varenicline Tartrate	20	suppressed
Bumetanide	Bumetanide	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Glimepiride	Glimepiride	19	11
Meclizine Hcl	Meclizine Hcl	19	12
Ondansetron Hcl	Ondansetron Hcl	19	suppressed
Nitroglycerin	Nitroglycerin	18	11
Benazepril Hcl	Benazepril Hcl	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Humulin N	Insulin Nph Human Isophane	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Liothyronine Sodium	Liothyronine Sodium	16	suppressed
Midodrine Hcl	Midodrine Hcl	16	suppressed
Amantadine	Amantadine Hcl	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	12
Clonidine Hcl	Clonidine Hcl	15	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Lamotrigine	Lamotrigine	15	12
Premarin	Estrogens, Conjugated	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	14	suppressed
Eplerenone	Eplerenone	14	suppressed
Fenofibrate	Fenofibrate,micronized	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	13	suppressed
Bydureon Bcise	Exenatide Microspheres	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Lactulose	Lactulose	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	13	suppressed
Primidone	Primidone	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Valsartan	Valsartan	13	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	12	suppressed
Digoxin	Digoxin	12	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	11	suppressed
Trospium Chloride	Trospium Chloride	11	suppressed
Trueplus Pen Needle	Pen Needle, Diabetic	11	suppressed
Zonisamide	Zonisamide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error